Roche (RHHBY) News Today $39.14 +0.16 (+0.41%) As of 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendHeadlinesInsider TradesOwnershipShort InterestBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Roche Announces Investments Of $50 Bln In The U.S. Over Next Five YearsApril 23 at 8:42 PM | nasdaq.comRoche to invest $50B in pharmaceuticals, diagnostics in the U.S. over 5 yearsApril 23 at 5:39 AM | markets.businessinsider.comRoche receives CE Mark for its Chest Pain Triage algorithm to enhance detection of Acute Coronary Syndrome (ACS)April 23 at 1:00 AM | globenewswire.comRoche to Invest $50 Billion in Pharma, Diagnostics in USApril 22 at 10:58 AM | bloomberg.comRoche says it will invest $50 billion in the U.S. as tariff fears hit pharmaApril 22 at 10:58 AM | finance.yahoo.comSwiss Pharma Giant Roche To Invest $50B in US Amid Tariff ThreatApril 22 at 8:41 AM | investopedia.comEuropean markets mixed as investors returned from Easter break, NVO and Roche in focusApril 22 at 5:57 AM | msn.comRoche to park $50B in U.S. over five years, create 12,000 jobsApril 22 at 5:57 AM | msn.comRoche to invest $50 billion in the U.S. as tariff threat lingersApril 22 at 3:09 AM | cnbc.comRoche to Invest $50 Billion in U.S. Manufacturing, R&D Amid Tariff ThreatsApril 22 at 2:03 AM | wsj.comRoche to invest $50 billion in United States over next five yearsApril 22 at 1:10 AM | reuters.comRoche to invest USD 50 billion in pharmaceuticals and diagnostics in the United States over the next five yearsApril 22 at 1:00 AM | globenewswire.comRoche (OTCMKTS:RHHBY) Stock Acquired Rep. Bruce WestermanRepresentative Bruce Westerman (R-Arkansas) recently bought shares of Roche Holding AG (OTCMKTS:RHHBY). In a filing disclosed on April 16th, the Representative disclosed that they had bought between $1,001 and $15,000 in Roche stock on March 3rd. The trade occurred in the Representative's "FISHER IApril 20 at 8:03 AM | marketbeat.comSterling Capital Management LLC Trims Position in Roche Holding AG (OTCMKTS:RHHBY)Sterling Capital Management LLC trimmed its position in Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 7.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 90,064 shares of the cApril 15, 2025 | marketbeat.comEuropean Commission approves Roche’s Columvi as the first bispecific antibody for diffuse large B-cell lymphoma after initial therapyApril 14, 2025 | uk.finance.yahoo.comRoche announces EC has approved Columvi to treat large B-cell lymphomaApril 14, 2025 | markets.businessinsider.comRoche (OTCMKTS:RHHBY) Stock Passes Below Fifty Day Moving Average - Time to Sell?Roche (OTCMKTS:RHHBY) Stock Price Crosses Below 50 Day Moving Average - Here's What HappenedApril 14, 2025 | marketbeat.comEuropean Commission approves Roche's Columvi as the first bispecific antibody for diffuse large B-cell lymphoma after initial therapyApril 14, 2025 | globenewswire.comThis Nvidia-Backed AI Stock Is Shrugging Off Market Pain Thanks to the FDA. Should You Buy Shares Now?April 11, 2025 | msn.comRoche: Forget Tariffs And Focus On The Positives -- There Are ManyApril 11, 2025 | seekingalpha.comZealand Pharma Goes on Hiring Spree as It Gears Up for Obesity Tie-Up With RocheApril 11, 2025 | wsj.comHealthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'April 9, 2025 | cnbc.comHealthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'April 9, 2025 | cnbc.comWhy Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped TodayApril 9, 2025 | fool.comWhy Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped TodayApril 9, 2025 | fool.comRoche price target raised to CHF 312 from CHF 305 at Morgan StanleyApril 5, 2025 | markets.businessinsider.comRoche Holding AG (OTCMKTS:RHHBY) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesRoche Holding AG (OTCMKTS:RHHBY - Get Free Report) has been given an average rating of "Moderate Buy" by the six ratings firms that are currently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, one has issued a hold recommendation, one hasApril 4, 2025 | marketbeat.comRoche’s Genentech present data on trontinemab, Elecsys plasma testApril 3, 2025 | markets.businessinsider.comEMA put clinical hold on Roche, Sarepta DMD studies after deathApril 3, 2025 | markets.businessinsider.comBeiGene slips on decision to halt lung cancer programApril 3, 2025 | msn.comSarepta falls after clinical hold related to Elevidys trialsApril 3, 2025 | msn.comRoche presents novel therapeutic and diagnostic advancements in Alzheimer’s at AD/PD 2025April 3, 2025 | finance.yahoo.comGenentech and Roche Present Novel Therapeutic and Diagnostic Advancements in Alzheimer's at AD/PD 2025April 3, 2025 | businesswire.comRoche presents novel therapeutic and diagnostic advancements in Alzheimer's at AD/PD 2025April 3, 2025 | globenewswire.comRoche stock falls following Ocrevus trial updateApril 2, 2025 | investing.comRoche says MUSETTE trial did not meet primary endpointApril 2, 2025 | markets.businessinsider.comWhy Is Pharma Giant Roche Stock Trading Lower On Wednesday?April 2, 2025 | benzinga.comGenentech Provides Update on Phase III Ocrevus High Dose Study in People With Relapsing Multiple SclerosisApril 2, 2025 | businesswire.comRoche fails in bid to increase dose of MS drug OcrevusApril 2, 2025 | reuters.comRoche provides update on Phase III OCREVUS high dose study in people with relapsing multiple sclerosisApril 2, 2025 | globenewswire.comQuest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer ScreeningApril 2, 2025 | prnewswire.comSaratoga Research & Investment Management Trims Position in Roche Holding AG (OTCMKTS:RHHBY)Saratoga Research & Investment Management lessened its stake in Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 6.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,174,306 shares of the company's stock after sellApril 1, 2025 | marketbeat.comShort Interest in Roche Holding AG (OTCMKTS:RHHBY) Decreases By 68.8%Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 3,665,700 shares, a decrease of 68.8% from the February 28th total of 11,741,100 shares. Approximately 0.1% of the company's stock are short sold. Based on an average trading volume of 5,260,100 shares, the short-interest ratio is currently 0.7 days.March 28, 2025 | marketbeat.comLarge pharma M&A deals stalling amid volatile policies, Reuters reportsMarch 27, 2025 | markets.businessinsider.comF. Hoffmann-La Roche Ltd: Roche Annual General Meeting 2025March 25, 2025 | finanznachrichten.deRoche Annual General Meeting 2025March 25, 2025 | globenewswire.comRoche abandons global diversity targets on concern over U.S. executive ordersMarch 19, 2025 | reuters.comOxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of CancerMarch 19, 2025 | globenewswire.comRoche (OTCMKTS:RHHBY) Sets New 1-Year High - Time to Buy?Roche (OTCMKTS:RHHBY) Sets New 1-Year High - Still a Buy?March 18, 2025 | marketbeat.comBig pharma fears drug price spikes in US-EU tariff spat, Reuters saysMarch 18, 2025 | markets.businessinsider.com Get Roche News Delivered to You Automatically Sign up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter. Email Address RHHBY Media Mentions By Week RHHBY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RHHBY News Sentiment▼0.360.76▲Average Medical News Sentiment RHHBY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RHHBY Articles This Week▼128▲RHHBY Articles Average Week Get Roche News Delivered to You Automatically Sign up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies China Construction Bank News EssilorLuxottica Société anonyme News Airbus News Iberdrola News Nintendo News BNP Paribas News Vinci News Atlas Copco News Compass Group News Bayerische Motoren Werke Aktiengesellschaft News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:RHHBY) was last updated on 4/23/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roche Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Roche With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
